D.E. Shaw & Co
OSRH

D.E. Shaw & Co’s OSR Health OSRH Stock Holding History

D.E. Shaw & Co’s Portfolio OSRH Stock Details OSRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-150,000
Closed -$1.57M – 4676
2023
Q3 		$1.57M Hold
150,000
– – ﹤0.01% 2771
2023
Q2 		$1.54M Hold
150,000
– – ﹤0.01% 2815
2023
Q1 		$1.51M Buy
+150,000
New +$1.52M ﹤0.01% 2883

Other funds holding OSRH

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

D.E. Shaw & Co's OSRH Position: Q4 2023 in Review

D.E. Shaw & Co sold out of OSR Health (OSRH) in Q4 2023, closing a stake of 150,000 shares — an estimated $1.57M sold.

D.E. Shaw & Co first reported a position in OSRH in Q1 2023 and held it in 3 quarters. The position peaked at $1.57M in Q3 2023. 24 funds tracked by Wall St. Rank hold OSRH as of Q4 2023.

  • D.E. Shaw & Co reported no remaining OSR Health position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 150,000 OSR Health shares in Q4 2023, an estimated $1.57M.
  • D.E. Shaw & Co first reported a position in OSR Health in Q1 2023 and held it in 3 quarters.
  • D.E. Shaw & Co's OSR Health position peaked at $1.57M in Q3 2023.
  • 24 funds tracked by Wall St. Rank held OSR Health as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.